Evidence map›Paper›PMID 33202679›Full record

ReviewBiomolecules2020

Florent Sebbane, Vladimir N Uversky, Andrey P Anisimov

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Journal of bacteriology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Virulence Reduction inBiomolecules · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Complete genome sequences ofMicrobiology resource announcements · 2025
    Article
  11. Review
  12. Multiplex PCR System for the Diagnosis of Plague.Current molecular medicine · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. PgtE Enzyme ofFrontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Florent SebbaneUniversité de Lille, Inserm, CNRS, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Center for Infection and Immunity of Lille, F-59000 Lille, France.
Vladimir N UverskyDepartment of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.ORCID 0000-0002-4037-5857
Andrey P AnisimovLaboratory for Plague Microbiology, State Research Center for Applied Microbiology and Biotechnology, Especially Dangerous Infections Department, 142279 Obolensk, Moscow Region, Russia.ORCID 0000-0002-5499-7999
Centre National de la Recherche Scientifique · FRState Research Center for Applied Microbiology and Biotechnology · RUUniversity of South Florida · US

Funding

Russian Science Foundation 19-15-00072
6 · The paper itself

Abstract

The Gram-negative bacterium

Indexed as

AnimalsAntigens, BacterialHumansPlaguePlague VaccinePlasminogen ActivatorsPoint MutationProtein Interaction MapsProtein Structure, SecondaryYersinia pestisAntigens, BacterialPlague VaccinePlasminogen Activatorsomptinpathogenesispathogenicity factorplagueplasminogen activatorYersinia pestis

Identifiers

PMID33202679
PMCPMC7696990
OpenAlexW3100974806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.